TaiGen Biopharmaceuticals Holdings Limited (4157.TWO)
TWD 8.97
(-7.33%)
TWD 8.97
(-7.33%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 58.71 Million TWD | 242.73% |
| 2022 | 17.13 Million TWD | -51.71% |
| 2021 | 35.47 Million TWD | 0.0% |
| 2020 | - TWD | -100.0% |
| 2019 | 17.12 Million TWD | 0.0% |
| 2018 | - TWD | 0.0% |
| 2017 | - TWD | 0.0% |
| 2016 | - TWD | 0.0% |
| 2015 | - TWD | 0.0% |
| 2014 | - TWD | 0.0% |
| 2013 | - TWD | 0.0% |
| 2012 | - TWD | 0.0% |
| 2011 | - TWD | 0.0% |
| 2010 | - TWD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 50.59 Million TWD | 0.0% |
| 2024 Q1 | 54.66 Million TWD | 0.0% |
| 2023 Q3 | 62.73 Million TWD | -6.0% |
| 2023 Q4 | 58.71 Million TWD | -6.42% |
| 2023 FY | 58.71 Million TWD | 242.73% |
| 2023 Q1 | 12.48 Million TWD | -27.1% |
| 2023 Q2 | 66.74 Million TWD | 434.44% |
| 2022 Q1 | 30.91 Million TWD | -12.83% |
| 2022 FY | 17.13 Million TWD | -51.71% |
| 2022 Q4 | 17.13 Million TWD | -21.23% |
| 2022 Q2 | 26.34 Million TWD | -14.79% |
| 2022 Q3 | 21.74 Million TWD | -17.45% |
| 2021 Q3 | - TWD | 0.0% |
| 2021 Q4 | 35.47 Million TWD | 0.0% |
| 2021 Q1 | - TWD | 0.0% |
| 2021 Q2 | - TWD | 0.0% |
| 2021 FY | 35.47 Million TWD | 0.0% |
| 2020 Q2 | 7.82 Million TWD | -37.34% |
| 2020 Q1 | 12.48 Million TWD | -27.08% |
| 2020 Q3 | 3.13 Million TWD | -59.9% |
| 2020 FY | - TWD | -100.0% |
| 2020 Q4 | - TWD | -100.0% |
| 2019 Q1 | 30.89 Million TWD | 0.0% |
| 2019 Q4 | 17.12 Million TWD | -21.23% |
| 2019 FY | 17.12 Million TWD | 0.0% |
| 2019 Q3 | 21.73 Million TWD | -17.43% |
| 2019 Q2 | 26.32 Million TWD | -14.79% |
| 2018 Q4 | - TWD | 0.0% |
| 2018 FY | - TWD | 0.0% |
| 2018 Q3 | - TWD | 0.0% |
| 2018 Q2 | - TWD | 0.0% |
| 2018 Q1 | - TWD | 0.0% |
| 2017 FY | - TWD | 0.0% |
| 2017 Q2 | - TWD | 0.0% |
| 2017 Q3 | - TWD | 0.0% |
| 2017 Q4 | - TWD | 0.0% |
| 2017 Q1 | - TWD | 0.0% |
| 2016 FY | - TWD | 0.0% |
| 2016 Q4 | - TWD | 0.0% |
| 2016 Q3 | - TWD | 0.0% |
| 2016 Q2 | - TWD | 0.0% |
| 2016 Q1 | - TWD | 0.0% |
| 2015 Q2 | - TWD | 0.0% |
| 2015 FY | - TWD | 0.0% |
| 2015 Q4 | - TWD | 0.0% |
| 2015 Q3 | - TWD | 0.0% |
| 2015 Q1 | - TWD | 0.0% |
| 2014 Q2 | - TWD | 0.0% |
| 2014 Q3 | - TWD | 0.0% |
| 2014 Q4 | - TWD | 0.0% |
| 2014 Q1 | - TWD | 0.0% |
| 2014 FY | - TWD | 0.0% |
| 2013 FY | - TWD | 0.0% |
| 2013 Q1 | - TWD | 0.0% |
| 2013 Q2 | - TWD | 0.0% |
| 2013 Q3 | - TWD | 0.0% |
| 2013 Q4 | - TWD | 0.0% |
| 2012 Q4 | - TWD | 0.0% |
| 2012 FY | - TWD | 0.0% |
| 2011 FY | - TWD | 0.0% |
| 2010 FY | - TWD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 60.65 Million TWD | 3.202% |
| Level Biotechnology Inc. | 9.88 Million TWD | -493.93% |
| Sagittarius Life Science Corp | 6.25 Million TWD | -838.759% |
| NeoCore Technology Co., Ltd. | 33.65 Million TWD | -74.462% |
| TaiMed Biologics Inc. | 521.7 Million TWD | 88.747% |
| GlycoNex Incorporation | - TWD | -Infinity% |
| VBI | - TWD | -Infinity% |
| GeneReach Biotechnology Corp. | 97.74 Million TWD | 39.934% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 86.89 Million TWD | 32.432% |
| Visgeneer Inc. | 114.17 Million TWD | 48.578% |
| Mycenax Biotech Inc. | 569.78 Million TWD | 89.696% |
| Sunmax Biotechnology Co., Ltd. | 144.77 Million TWD | 59.447% |
| G&E Herbal Biotechnology Co., Ltd. | 1.29 Million TWD | -4437.094% |
| Medigen Vaccine Biologics Corporation | 254.35 Million TWD | 76.918% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 472 Thousand TWD | -12338.559% |
| Enimmune corporation | 1.75 Million TWD | -3237.692% |
| TaiRx, Inc. | 8.96 Million TWD | -554.588% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| EirGenix Inc. | 436.54 Million TWD | 86.551% |
| BioLASCO Taiwan Co., Ltd. | 51.43 Million TWD | -14.149% |
| Sunny Pharmtech Inc. | 376.29 Million TWD | 84.398% |
| Lin BioScience, Inc. | 29.02 Million TWD | -102.267% |
| BioGend Therapeutics Co., Ltd. | 9.44 Million TWD | -521.862% |
| Feng Chi Biotech Corp. | 8.14 Million TWD | -620.456% |
| Bio Preventive Medicine Corp. | 106.2 Million TWD | 44.718% |
| Lukas Biomedical Inc. | 69.9 Million TWD | 16.015% |
| RBC Bioscience Corporation | 412.59 Million TWD | 85.771% |
| BiOptic Inc. | 85.79 Million TWD | 31.567% |
| BRIM Biotechnology, Inc. | 108 Thousand TWD | -54261.111% |
| Shine-On BioMedical Co.,Ltd. | - TWD | -Infinity% |
| Great Novel Therapeutics Biotech & Medicals | 10.88 Million TWD | -439.564% |
| Syngen Biotech Co.,Ltd. | 386.07 Million TWD | 84.793% |
| Anti-Microbial Savior BioteQ Co., Ltd | - TWD | -Infinity% |
| SynCore Biotechnology Co.,Ltd | - TWD | -Infinity% |
| Genomics BioSci & Tech. Co.,Ltd. | 222.24 Million TWD | 73.583% |
| Neith Corporation | 714 Thousand TWD | -8122.689% |
| Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
| NaviFUS Corp. | 25.83 Million TWD | -127.232% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 366 Million TWD | 83.959% |
| Sinew Pharma Inc. | - TWD | -Infinity% |
| Andros Pharmaceuticals Co.,Ltd | 22.02 Million TWD | -166.573% |
| Greenyn Biotechnology Co., Ltd | 55.91 Million TWD | -4.995% |
| Lumosa Therapeutics Co., Ltd. | 8.11 Million TWD | -623.297% |
| AP Biosciences Inc | 70.42 Million TWD | 16.637% |
| Medigen Biotechnology Corp. | 449.09 Million TWD | 86.927% |
| 3D Global Biotech Inc. | 4.08 Million TWD | -1338.266% |
| Pharmosa Biopharm Inc. | 118.41 Million TWD | 50.42% |
| Intech Biopharm Corporation | 970.4 Million TWD | 93.95% |
| Oneness Biotech Co., Ltd. | 397.95 Million TWD | 85.247% |
| Eusol Biotech Co.,Ltd. | 1.6 Million TWD | -3555.666% |
| TWi Biotechnology, Inc. | 5.6 Million TWD | -947.832% |
| Ever Supreme Bio Technology Co., Ltd | 503 Thousand TWD | -11571.968% |
| TCI GENE Inc. | - TWD | -Infinity% |
| MegaPro Biomedical Co., Ltd | 5.62 Million TWD | -943.177% |
| Senhwa Biosciences, Inc. | 3.28 Million TWD | -1686.127% |
| Taiwan Bio Therapeutics Co., Ltd | 250.51 Million TWD | 76.564% |
| NatureWise Biotech & Medicals Corporation | 3.26 Million TWD | -1698.162% |
| PharmaEngine, Inc. | 7.14 Million TWD | -721.924% |
| Savior Lifetec Corporation | 257.03 Million TWD | 77.159% |
| OBI Pharma, Inc. | 439.88 Million TWD | 86.653% |
| Meribank Biotech Co., Ltd | 14.81 Million TWD | -296.395% |
| Acepodia, Inc. | 233.45 Million TWD | 74.851% |
| Caliway Biopharmaceuticals Co., Ltd. | 11.87 Million TWD | -394.442% |